IRIS
DI CARLO, EMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.231
AS - Asia 4.607
EU - Europa 4.414
SA - Sud America 618
AF - Africa 73
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.137
SG - Singapore 1.762
CN - Cina 1.403
UA - Ucraina 777
IE - Irlanda 631
TR - Turchia 570
GB - Regno Unito 553
RU - Federazione Russa 518
BR - Brasile 504
IT - Italia 504
SE - Svezia 457
FR - Francia 401
VN - Vietnam 390
DE - Germania 270
IN - India 193
FI - Finlandia 163
HK - Hong Kong 56
AR - Argentina 43
MX - Messico 41
BD - Bangladesh 39
CA - Canada 37
PL - Polonia 32
IQ - Iraq 26
EC - Ecuador 24
NL - Olanda 24
ES - Italia 23
KR - Corea 23
ZA - Sudafrica 23
JP - Giappone 22
PK - Pakistan 21
BE - Belgio 16
UZ - Uzbekistan 13
AT - Austria 12
CL - Cile 12
ID - Indonesia 11
IL - Israele 11
KE - Kenya 11
EG - Egitto 10
SA - Arabia Saudita 10
MA - Marocco 9
PY - Paraguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
CO - Colombia 7
JO - Giordania 7
CZ - Repubblica Ceca 6
LT - Lituania 6
NP - Nepal 6
AU - Australia 5
ET - Etiopia 5
HU - Ungheria 5
KZ - Kazakistan 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
PE - Perù 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IR - Iran 3
JM - Giamaica 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
KW - Kuwait 2
OM - Oman 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.954
Salva come PNG Salva come JPEG
Città #
Singapore 1.243
Jacksonville 841
Chandler 702
San Jose 702
Dublin 627
Southend 387
Dearborn 382
Princeton 310
Beijing 304
Ashburn 300
Dallas 282
Izmir 264
Nanjing 251
Wilmington 173
Los Angeles 141
Cambridge 140
The Dalles 129
Tongling 118
Ho Chi Minh City 117
New York 105
Altamura 98
Council Bluffs 94
Santa Clara 90
Hanoi 78
Nanchang 78
Buffalo 75
Ann Arbor 73
Boardman 69
Chieti 68
Moscow 62
Hong Kong 55
Woodbridge 54
Shenyang 47
Pescara 44
Hefei 43
São Paulo 43
Hebei 39
Romola 37
Chennai 36
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 31
Redondo Beach 30
Houston 28
Tianjin 28
Warsaw 27
Orem 25
Guangzhou 21
Hangzhou 21
Seoul 21
Tokyo 20
Denver 19
Jinan 19
Norwalk 19
Da Nang 18
Brooklyn 17
Changsha 17
Düsseldorf 17
Helsinki 17
Johannesburg 17
Boston 16
Orange 16
Amsterdam 15
Atlanta 15
Chicago 15
Manchester 15
Frankfurt am Main 14
San Francisco 14
Toronto 14
Mexico City 13
Milan 13
Phoenix 13
Poplar 13
Lanciano 12
Tashkent 12
Brussels 11
Falls Church 11
Haiphong 11
Munich 11
Nuremberg 11
Rio de Janeiro 11
Auburn Hills 10
Augusta 10
Curitiba 10
London 10
Nairobi 10
Baghdad 9
Belo Horizonte 9
Leawood 9
Ninh Bình 9
Seattle 9
Stockholm 9
Washington 9
Caxias do Sul 8
Changchun 8
Lanzhou 8
Ningbo 8
San Mateo 8
Shanghai 8
Totale 9.652
Salva come PNG Salva come JPEG
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 155
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 152
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 152
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 149
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 147
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 145
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 144
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 143
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 141
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 141
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 138
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 134
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 133
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 133
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 132
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 132
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 130
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 130
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 129
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 129
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 128
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 128
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 128
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 126
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 126
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 124
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 124
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 123
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 123
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 123
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 122
Interleukin-30 Promotes Breast Cancer Growth and Progression 122
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 121
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 121
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 120
Targeting tumor-related immunosuppression for cancer immunotherapy. 120
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 118
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 117
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 117
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 117
Neutrophils in anti-cancer immunological strategies: old players in new games 116
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 115
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 115
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 115
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 115
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 115
Clinical impact of the lung tissue transcriptome in a teenager with multifocal invasive mucinous adenocarcinoma-a case report 115
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 114
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 113
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 113
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 112
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 111
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 111
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 111
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 111
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 111
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 110
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 110
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 110
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 110
The role of B lymphocytes and NK cells in cardiac allograft rejection. 109
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 109
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 109
The Quilty Effect: an actor in search of a part 108
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 108
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 107
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 107
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 106
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 106
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 106
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 105
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 105
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 104
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. 104
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 103
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 103
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 103
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 102
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 102
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 102
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 102
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 101
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 100
Immunological prevention of a multigene cancer syndrome. 100
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells 100
Oxidative Stress and Age-Related Tumors 99
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 98
Gene transfer of a modified human IL-15 cDNA in lung cancer cells: analyses of biological effects. 98
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 98
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. 97
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 97
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 97
The antitumor potential of Interleukin-27 in prostate cancer 97
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 96
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 96
Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway 95
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 95
Role of IL-21 in immune-regulation and tumor immunotherapy. 95
Neutrophils in the antitumoral immune response 95
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival 95
Totale 11.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/20252.435 157 318 316 95 44 62 38 152 296 134 300 523
2025/20264.852 459 305 553 640 397 318 865 442 521 352 0 0
Totale 16.512